In recent years, I’ve worked across the Havas network on both HCP and DTC accounts. These roles required navigating complex regulatory frameworks, crafting messages for diverse audiences, and ensuring scientific information was communicated with accuracy, clarity, and impact.

From 2022–2024, I worked extensively on Otezla, an oral treatment for psoriasis. During this time, I developed social campaigns, in-office posters, and print materials, while also contributing to the television campaign that launched in summer 2024. One highlight was the Psomething Different social campaign, which I created with my partner and guided from initial strategy through to execution, developing both the visual concepts and copy across captions and imagery.

In 2025, I wrote an HCP campaign and microsite touting Arrowhead Pharmaceuticals’ commitment to advancing the science of high triglyceride management. The campaign launched as part of Rare Disease Month and headlined at the American Heart Association’s Scientific Sessions in Chicago.

Click on the image below to be directed to the live asset.

Working on oncology concepts has been both rewarding and educational. The assets below represent a range of campaigns my partner and I developed for a new B-cell lymphoma treatment.

Along with my partner, I created the “Next is Greater” campaign for Otezla’s 10-year anniversary. This work celebrates a decade of Otezla’s impact and embodies the brand’s forward-looking vision.